Return on assets of Retrophin, Inc.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for adjunctive treatment of patients with peroxisomal disorders; and Thiola, a tiopronin tablet for the treatment of cystinuria. The company's product candidates consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis; Fosmetpantotenate, a novel small molecule that is in Phase III clinical trial to treat pantothenate kinase-associated neurodegeneration; Tetracosactide Zinc (RE-034), a synthetic hormone analog that is in preclinical stage; and Liquid Ursodeoxycholic Acid, a liquid formulation of ursodeoxycholic acid, which is in preclinical stage to treat primary biliary cholangitis. Retrophin, Inc. was founded in 2011 and is headquartered in San Diego, California.
|BOH Bank of Hawaii Corporation||NYSE > Finance > Major Banks||2.93|
|BLD TopBuild Corp.||NYSE > Basic Industries > Engineering & Construction||2.93|
|BREW Craft Brew Alliance, Inc.||NASDAQ > Consumer Non-Durables > Beverages (Production/Distribution)||2.93|
|CSSE Chicken Soup for the Soul Entertainment, Inc.||NASDAQ > Consumer Services > Movies/Entertainment||2.93|
|FNV Franco-Nevada Corporation||NYSE > Basic Industries > Precious Metals||2.93|
|ACXM Acxiom Corporation||NASDAQ > Technology > EDP Services||2.93|
|RTRX Retrophin, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||2.93|
|BRACU Black Ridge Acquisition Corp.||NASDAQ > Finance > Business Services||1,482.86|
|VNCE Vince Holding Corp.||NYSE > Consumer Services > Clothing/Shoe/Accessory Stores||1,676.00|
|ANTH Anthera Pharmaceuticals, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||1,690.00|
|W Wayfair Inc.||NYSE > Consumer Services > Catalog/Specialty Distribution||2,786.29|
|HYAC Haymaker Acquisition Corp.||NASDAQ||3,183.33|
|CMSS CM Seven Star Acquisition Corporation||NASDAQ > Finance > Business Services||4,865.00|